PARP1 and cervical carcinoma: XIAP, an apoptosis inhibitor directly restraining the caspase activity, exhibits an apoptosis inhibitory function in cervical cancer cells because its deficiency leads to upregulated cleaved caspase-3 and PARP1 protein levels (Supplementary Figure S3).